Alpha Wealth Funds’s Maravai LifeSciences MRVI Stock Holding History

Alpha Wealth Funds’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$207K	Hold	72,000	–	–	0.14%	33
2025 Q4	$245K	Hold	72,000	–	–	0.15%	41
2025 Q3	$176K	Hold	72,000	–	–	0.13%	40
2025 Q2	$176K	Hold	72,000	–	–	0.15%	39
2025 Q1	$159K	Buy	72,000 +2,000	+3%	+$7.9K	0.16%	36
2024 Q4	$386K	Buy	+70,000	New	+$450K	0.37%	36

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Alpha Wealth Funds's MRVI Position: Q1 2026 in Review

Alpha Wealth Funds held its Maravai LifeSciences (MRVI) position steady in Q1 2026 at 72,000 shares worth $207K. The position accounts for 0.14% of the portfolio, ranked #33.

Alpha Wealth Funds first reported a position in MRVI in Q4 2024 and has held it in 6 quarters since. The position peaked at $386K in Q4 2024. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

Alpha Wealth Funds held 72,000 shares of Maravai LifeSciences worth $207K as of Q1 2026.
Alpha Wealth Funds left its Maravai LifeSciences share count unchanged in Q1 2026.
Maravai LifeSciences made up 0.14% of Alpha Wealth Funds's portfolio in Q1 2026, its #33 holding.
Alpha Wealth Funds first reported a position in Maravai LifeSciences in Q4 2024 and has held it in 6 quarters since.
Alpha Wealth Funds's Maravai LifeSciences position peaked at $386K in Q4 2024.
158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on Alpha Wealth Funds's 13F filing for Q1 2026, filed 14 May 2026.